Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer - Wikidata - awgldk - TriplyDB

Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer

Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer

http://www.wikidata.org/entity/Q37170747

about

HIF-1: upstream and downstream of cancer metabolism HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers.Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer.Prolactin/Stat5 and androgen R1881 coactivate carboxypeptidase-D gene in breast cancer cells Minireview: Estrogen receptor-beta: mechanistic insights from recent studies.HIF1/2α mediates hypoxia-induced LDHA expression in human pancreatic cancer cells Zinc downregulates HIF-1α and inhibits its activity in tumor cells in vitro and in vivo Epithelial-mesenchymal transition in prostate cancer: an overview.A phosphotyrosine switch determines the antitumor activity of ERβ.Histone deacetylase inhibition enhances self renewal and cardioprotection by human cord blood-derived CD34 cells.Toll-like receptor 3 regulates angiogenesis and apoptosis in prostate cancer cell lines through hypoxia-inducible factor 1 alpha Roles of tetrahydrobiopterin in promoting tumor angiogenesis In vitro epigenetic reprogramming of human cardiac mesenchymal stromal cells into functionally competent cardiovascular precursors.HIF-1α antagonizes p53-mediated apoptosis by triggering HIPK2 degradation.Estrogen-dependent dynamic profile of eNOS-DNA associations in prostate cancer A therapeutic role for targeting c-Myc/Hif-1-dependent signaling pathways.Estrogens and prostate cancer: etiology, mediators, prevention, and management.DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex.Hypoxia-inducible miR-182 enhances HIF1α signaling via targeting PHD2 and FIH1 in prostate cancer.STAT3 can serve as a hit in the process of malignant transformation of primary cells.Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells.A nitric oxide-dependent cross-talk between class I and III histone deacetylases accelerates skin repair Ex vivo acidic preconditioning enhances bone marrow ckit+ cell therapeutic potential via increased CXCR4 expression.Detrimental effect of class-selective histone deacetylase inhibitors during tissue regeneration following hindlimb ischemia.Role of endothelial nitric oxide synthase (eNOS) in chronic stress-promoted tumour growth.Dual tumor suppressing and promoting function of Notch1 signaling in human prostate cancer.Genetic variants within endothelial nitric oxide synthase gene and prostate cancer: a meta-analysis.Hypoxia and inflammation.The role of treatment modality on the utility of predictive tissue biomarkers in clinical prostate cancer: a systematic review.Human ASH-1 promotes neuroendocrine differentiation in androgen deprivation conditions and interferes with androgen responsiveness in prostate cancer cells.The role of nuclear endothelial nitric oxide synthase in the endothelial and prostate microenvironments.Establishment of a protocol to extend the lifespan of human hormone-secreting pituitary adenoma cells.The nuclear pore protein Nup153 associates with chromatin and regulates cardiac gene expression in dystrophic mdx hearts.Nitric Oxide Up-Regulates RUNX2 in LNCaP Prostate Tumours: Implications for Tumour Growth In Vitro and In Vivo.MALAT1 and HOTAIR Long Non-Coding RNAs Play Opposite Role in Estrogen-Mediated Transcriptional Regulation in Prostate Cancer Cells.Testosterone and prolactin increase carboxypeptidase-D and nitric oxide levels to promote survival of prostate cancer cells.

P2860

Q24647482-745A50F9-A80A-4692-AA71-096934DA4AF4 Q27025886-A033B5A7-EA6E-4C93-AA80-A0379664356A Q27851557-97F3FD27-EA61-4502-A0C9-29C7E85600A7 Q28393898-10FAD6E0-F120-4A30-A81A-E2A6C5401BA1 Q29615944-DAFEBC24-CC8D-427F-9427-D2B2FA2CE848 Q33606107-13F0E9FC-B9B5-4C0D-9421-D5615E2FAE69 Q33632218-34695937-A7D6-4CF6-A7EA-F0C166F77FA7 Q33637261-C23FD7B3-ED3B-4D9A-9DAC-245B2C198D78 Q33648672-ED0512B5-C088-437C-9086-E92627AD44CE Q33778211-B1A31EDF-014C-4286-985E-07772098AA1B Q33798864-B7D477A9-059B-43DE-90D1-EB7A1CB01F6F Q33944154-DC0ECAF6-FEAE-405E-AE03-4F6B2034F46D Q33971323-E8A73180-5391-4A25-BD28-EC783861E76B Q34009839-73BCF833-40DC-43E6-8165-516AC28EDF1E Q34254651-CB171BF0-6D7F-451E-9B38-596E6BE884CB Q34532172-D28CF89A-01E2-430C-A352-9AFC5E29E115 Q34616703-C86401C3-03EC-4F3D-BDC4-99DBD5445D77 Q34712579-23F8F82A-FF2E-463F-B365-B957713822EB Q35163974-02C494DB-36CC-47F8-9940-60D1E1FBA2D0 Q35196710-DBCC335C-AFEF-467F-8DED-CE70401E7B75 Q35206363-6732D126-CB7D-4D03-81C6-CB2C0DA9488E Q35595690-539F721B-B558-4375-9718-9743BF539A0E Q35884549-76E1927B-EFBA-402B-B384-0311181CA504 Q36084487-A3A15B40-F45B-4A61-91AD-C506D87135E3 Q36275660-67A0723C-D1AB-4C43-97D2-F735E4266202 Q36779668-79ECCB16-1BCB-4BCD-9422-EC9503BE5763 Q36988250-EEE7C672-1951-4766-8DDF-B916AF1DCEC8 Q37095364-70157E9C-C5EF-4383-B689-733F46B16F7A Q37294667-C54B3987-E944-49C0-A43B-F5263B5DC8A0 Q37565364-A94643D9-B6A6-49F9-9EBF-7982D39FB22A Q37700582-39E72C69-5BA0-4943-962F-2D3AE6436600 Q37842498-28F50E60-F1E1-44AF-8EA1-A1F9F63DA9E3 Q38063121-F4EF9477-0565-4B82-9470-4FED9FAEDB19 Q38421322-D5D938FB-AEF7-4F00-9B9A-9BD083F28DB4 Q38471524-01636C1E-1070-4850-B243-359604A62E36 Q38690409-C5F3BD94-F137-40FE-82C4-151269E731BB Q38780863-79F28AAA-9AB7-483B-8D42-0D877B03A377 Q38851486-E8443D30-C9D4-426C-800C-601D51B1D305 Q39127487-9BC54B8D-F316-4830-8E6B-71CAD74ACA38 Q39521501-E6D1A24B-B1CE-4F82-B0E9-8193D7B7E8E5

P2860

Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer

http://www.wikidata.org/entity/Q37170747

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 April 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Endothelial NOS, estrogen rece ...... gressive human prostate cancer

@en

Endothelial NOS, estrogen rece ...... ressive human prostate cancer.

@nl

type

label

Endothelial NOS, estrogen rece ...... gressive human prostate cancer

@en

Endothelial NOS, estrogen rece ...... ressive human prostate cancer.

@nl

prefLabel

Endothelial NOS, estrogen rece ...... gressive human prostate cancer

@en

Endothelial NOS, estrogen rece ...... ressive human prostate cancer.

@nl

P1433

Q37170747-D3E89625-5884-4FB2-A4BA-3BC61284C7D0

P1476

Q37170747-C447FEFA-60F5-46BF-9C26-53AEC8DFF4C2

P2093

Q37170747-0DBBDF35-3E0A-43F3-80E3-5E6B715F532F

Q37170747-216C5561-7621-4328-ABC3-48C131F1EFE9

Q37170747-2D94DD28-AEFE-441F-B81C-ECA27E845B51

Q37170747-3453290D-4042-420C-8F56-36F59B5D8133

Q37170747-4DDB571A-9765-4C49-86FB-83696C07ECC0

Q37170747-4FDFFF00-B1B8-4D3F-9FAB-E62DE65B140F

Q37170747-50C0E630-BBF9-42FB-BE65-8479E58EB375

Q37170747-777BAE52-2B2D-4BBD-831E-680F88038629

Q37170747-81880750-0231-4EAF-AAC6-357A717B0B69

Q37170747-8A4C77FC-51C8-44F7-AFFA-55D45524EC30

P2860

Q37170747-010FB9BD-0610-4D1A-A92A-3441FA00A78D

Q37170747-012B7331-B2BF-4114-8848-891671317444

Q37170747-01861D8D-D743-4B4E-94AE-502718A56992

Q37170747-09689618-F5A1-41CB-BD62-D22653388670

Q37170747-0AD219AE-21DC-4160-A72E-ABFFB516D413

Q37170747-111FB72E-7E64-41CF-AAF5-AE0BC0A29C19

Q37170747-157EE550-67D3-4713-A135-79B917DF5D02

Q37170747-17B610DF-8995-4C96-B54E-8D2ECD95ED6D

Q37170747-182B72C3-6CF2-42E5-A19C-75524D904224

Q37170747-215DFD1C-AA5D-45C2-8EFE-1B4B11C032AF

P304

Q37170747-65F9CB67-ACD4-4B27-BCEA-757A0A8E71DD

P31

Q37170747-ADAB2907-0B5F-4C3F-ACCA-0958A3118182

P356

Q37170747-50DB9A63-A359-44A0-9B39-672C0C2DFC3F

P407

Q37170747-ABC1D212-1195-4FCC-9341-2989CA7B6A22

P433

Q37170747-4A0E21E4-B63D-4040-8484-BCBF37D3CD8C

P478

Q37170747-FE403BB1-B57B-40B9-8145-264017EC151F

P50

Q37170747-1639CCD8-2602-4694-BC4A-33137A3EB250

Q37170747-43825C51-C233-4FD6-B0D2-1D031426696D

Q37170747-5770B50F-3D80-4AA7-A220-C5AAEB180D87

Q37170747-61534B3A-29D0-4FD3-8F17-389DB781625F

Q37170747-6377F630-E923-41A7-A2D7-8AA622CDA249

Q37170747-66793654-6382-4C03-B49D-567D8ED81F58

Q37170747-EE2B7806-B37F-4996-987C-CA5AB04F1A53

Q37170747-FCC3E655-C650-4469-8D1F-BDC065AFEB7B

P577

Q37170747-C348B24A-C3A3-4B19-AB74-8BC53DA938D2

P5875

Q37170747-199E65A3-8A1C-46F8-9FB2-4D9E3C10CD97

P698

Q37170747-D7F6F1CA-5048-4019-82AB-FAAF1707646E

P921

Q37170747-1DE9155A-40B5-40BF-B33C-A9824E399337

P932

Q37170747-471EDA0A-2F85-44B2-ADD5-7D908924F762

P356

P1433

Journal of Clinical Investigation

P1476

Endothelial NOS, estrogen rece ...... gressive human prostate cancer

@en

P2093

Ada Sacchi

http://www.w3.org/2001/XMLSchema#string

Alfredo Pontecorvi

http://www.w3.org/2001/XMLSchema#string

Anna Maria Cianciulli

http://www.w3.org/2001/XMLSchema#string

Annalisa Grasselli

http://www.w3.org/2001/XMLSchema#string

Antonella Farsetti

http://www.w3.org/2001/XMLSchema#string

Aurora Aiello

http://www.w3.org/2001/XMLSchema#string

Barbara Illi

http://www.w3.org/2001/XMLSchema#string

Carmen Priolo

http://www.w3.org/2001/XMLSchema#string

Elke Mueller

http://www.w3.org/2001/XMLSchema#string

Giorgio Arcangeli

http://www.w3.org/2001/XMLSchema#string

P2860

Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer

Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers

Targeting HIF-1 for cancer therapy

Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases

Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1

Why do cancers have high aerobic glycolysis?

Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription

Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma.

Expression of estrogen receptor beta in the fetal, neonatal, and prepubertal human prostate.

Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis.

P304

1093-1108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI35079

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P50

Marcella Mottolese

Stephen P. Finn

Michele Gallucci

Manuela D'Eletto

Claudia Colussi

P577

2009-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24274662

http://www.w3.org/2001/XMLSchema#string

P698

19363294

http://www.w3.org/2001/XMLSchema#string

P921

P932

2673846

http://www.w3.org/2001/XMLSchema#string